The October 2009 Physics Today cover story looks at the work on superhydrophobic surfaces being done by several researchers in the Mechanical and Industrial Engineering Department. As the story notes, “Researchers led by Jonathan Rothstein at the University of Massachusetts Amherst now offer a proof-of-principle demonstration of a new, passive option for reducing drag in a turbulent flow.
University of Massachusetts Amherst mechanical engineering sophomore Samuel del Pilar of Flushing, New York, is one of 75 students nationwide selected for scholarships from the Hispanic Engineer National Achievement Awards Conference (HENAAC). He is the second UMass Amherst engineering student to receive a HENAAC scholarship, the first being Rafael Santana, who graduated in 2004 with a degree in computer systems engineering.
Two mechanical engineering students at the University of Massachusetts Amherst have literally taken advantage of a windfall from a prominent wind power company and used it to propel their futures. Jacque Heger and Samuel Deptula each received $5,000 scholarships for the 2008-2009 academic year from Vestas Americas, the leading supplier of wind power solutions with over 35,000 wind turbines installed.
The UMass Amherst Supermileage Vehicle Team successfully fielded two vehicles this year at the annual Society of Automotive Engineers Supermileage Vehicle competition, held at the Eaton Corporation Proving Grounds in Marshall, Michigan, on June 4th and 5th.
The search committee looking for the new head of the Mechanical and Industrial Engineering Department has chosen MIE Professor Donald Fisher to replace the departing Mario Rotea. “I am delighted to inform you that Professor Donald L. Fisher has accepted the position of Department Head in Mechanical and Industrial Engineering, effective July 1, 2009,” announced Dean Mike Malone. “Dr. Fisher has a distinguished record of research, teaching, and service over more than two decades on the faculty at UMass Amherst.”
The UMass Amherst Wind Energy Center's pre-development team has installed anemometry on the WFCR tower on Mount Lincoln in Pelham as part of a state-sponsored project to evaluate the wind resource and see if it’s feasible for UMass to install a wind turbine at that site. Depending on how favorable the resource is, UMass might install a 1.5-2 MW wind turbine that would supplement its new combined heat and power plant, making the campus even greener.
Industrial engineering majors Dana Evernden and Noah Duffey both look like pictures of good health. But their key role on an interdisciplinary team of engineering and nursing researchers is to act like 73-year-old diabetics with high blood pressure and eye problems. Their work is helping to develop a new, high-tech tool that will make it a lot easier for diabetics to manage their disease and maintain their health.
Jonathan Rothstein, a faculty member in the Mechanical and Industrial Engineering Department at the University of Massachusetts Amherst, has just been announced as the first recipient of the newly created Arthur B. Metzner Early Career Award, presented by the 1,700-member Society of Rheology, a member society of the American Institute of Physics. This award recognizes a young society member who “has distinguished him/herself in rheological research, rheological practice, or service to rheology.”
Precision Slip, a concept-stage business that plans to manufacture a laboratory-proven, drag-reducing, marine coating capable of slashing fuel consumption by at least 40 percent in a typical merchant ship, has won the fifth annual Executive Summary Competition, staged by the UMass Amherst Entrepreneurship Initiative (UMass EI). Precision Slip received the first prize of $3,500, plus another $500 for the People’s Choice Award, voted on by the audience.
Millis resident William Vogt, a senior mechanical engineering student at the University of Massachusetts Amherst, is using a tried and true engineering discipline, called “control theory,” to give medical doctors a better way to regulate a life-enhancing medication for kidney patients. The medication is recombinant erythropoietin (rhEPO), which stimulates the failing production of red blood cells in kidney patients, but is currently very difficult to regulate effectively.